AVEENO Baby Dermexa Emollient Cream 150 ml, Packaging May Vary
Original price was: £7.50.£4.95Current price is: £4.95.
AVEENO Baby Dermexa™ Emollient Cream is specially formulated for babies with very dry, itchy skin who are more prone to regular irritation and itchiness. Enriched with ceramides, an essential component of the skin structure, the formula helps to strengthen the skin barrier function. AVEENO Baby Dermexa™ Emollient Cream contains our highest concentration of oat extract*, oat oil and prebiotic oatmeal for healthy looking, more resilient skin from Day 1. It is free from parabens and can be applied to the whole body twice a day. This Emollient Cream comes in a recyclable carton, which is FSC certified. *versus all other AVEENO® Baby products For a complete routine use with AVEENO Baby Dermexa™ Moisturising Wash, and for long lasting comfort at night use AVEENO Baby Dermexa™ Good Night Emollient Balm. At AVEENO® Baby we carefully select high quality oats to preserve their protective, moisturising and soothing properties. About AVEENO® Baby Our AVEENO® Baby products are specially formulated to provide daily care to soothing care for your little one. AVEENO® Baby products are paediatrician and dermatologist tested, and dye free. They nourish, soothe & protect sensitive baby skin from the 1st use.
Product Dimensions : 4.5 x 4.5 x 15 cm; 0.15 g
Manufacturer : Kenvue (Johnson & Johnson Ltd)
ASIN : B09NDZ2WL1
Item model number : 112522575
Country of origin : France
WITH OUR HIGHEST CONCENTRATION OF OAT EXTRACT, OAT OIL AND PREBIOTIC OATMEAL: the formula leaves healthy looking, more resilient skin from day 1. versus all other AVEENO Baby products
WITH TRIPLE OAT COMPLEX & CERAMIDES: Enriched with ceramides, an essential component of the skin structure, the formula helps to strengthen the skin barrier function.
FOR VERY DRY, ITCHY SKIN: Babies with very dry, itchy skin are more prone to regular irritation and itchiness.
ALSO SUITABLE FOR LITTLE ONES WHO MAY BE PRONE TO ECZEMA
FREE FROM PARABENS
There are no reviews yet.